Target intelligence / Profile preview

Cardiolipin-rich and lipid II-associated membrane microdomain (CL-Lipid II microdomain)

Target
CL-Lipid II microdomain
Molecular classification
Membrane microdomain, Lipid-protein complex, Bacterial cell membrane component
01

Overview

Cardiolipin-rich and lipid II-associated membrane microdomains are specialized, functional regions within the bacterial plasma membrane, primarily characterized in Gram-positive species such as Staphylococcus aureus and Bacillus subtilis. These domains act as organizational scaffolds that co-localize lipid II, a vital precursor for peptidoglycan synthesis, with cardiolipin, a phospholipid that aids in the recruitment and stabilization of membrane-associated proteins involved in cell wall assembly and division (Müller et al., 2016, Science). By concentrating these essential components, the microdomains facilitate efficient bacterial growth and maintain structural integrity. These domains are a critical therapeutic target for the lipopeptide antibiotic daptomycin, which requires both cardiolipin and lipid II for optimal binding and membrane insertion (Grein et al., 2020, Nature Communications). Interaction with these domains leads to the displacement of peripheral membrane proteins like MurG and DivIVA, resulting in the catastrophic failure of cell wall synthesis and rapid bacterial cell death through membrane depolarization.

Other names
Bacterial lipid raftsFunctional membrane microdomains (FMMs)Cardiolipin-rich domainsLipid II-containing microdomains
02

Mechanism of action

Antibiotics like daptomycin bind to these microdomains in a calcium-dependent manner, causing the displacement of essential cell wall synthesis proteins and inducing membrane depolarization or pore formation.

03

Biological functions

Cell wall biosynthesisMembrane organizationProtein localizationPeptidoglycan synthesisCell division coordination
04

Disease associations

Bacterial infectionGram-positive bacterial infectionAntimicrobial resistance
05

Safety considerations

Development of antibiotic resistance through membrane remodeling (e.g., mprF gene mutations)Potential (though minimal) cross-reactivity with mitochondrial cardiolipin in host cellsAlterations in bacterial membrane charge affecting drug binding
06

Interacting drugs

Daptomycin

4 more in the full profile.

07

Biomarkers

Cardiolipin concentrationLipid II levelsMembrane fluidityMurG localizationDivIVA localization

Beyond the preview

Go deeper on Cardiolipin-rich and lipid II-associated membrane microdomain (CL-Lipid II microdomain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiolipin-rich and lipid II-associated membrane microdomain (CL-Lipid II microdomain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call